 |
|
|
|
|
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Murphy M. on PAPER: Watanabe T. et al., 2012, This is a really interesting and exciting paper. Although we’ve known for some time that the... 9 Mar 2012.
|
|
|
 |
|
|
Murphy M. on NEWS: Barcelona: 10th AD/PD Conference Hosts a Shaken, Restive Field, The AD/PD conference is a unique mixture of researchers in neurodegenerative disease from around... 28 Mar 2011.
|
|
|
|
|
|
Murphy M. on NEWS: Mark Smith, 45, Is Struck and Killed by Hit-and-Run Driver, This is a terrible loss to the field. Mark was a much-needed counter voice against the most... 27 Dec 2010.
|
|
|
|
|
|
Murphy M. on PAPER: Hasegawa T. et al., 2010, I agree with Dr. Hasegawa that we may need to rethink how we are doing (and interpreting) our... 19 Feb 2010.
|
|
|
|
|
|
Murphy M. on NEWS: Paper Alert—Phase 3 Tarenflurbil Data Published, What has always been remarkable about preclinical work in mice is just how extraordinarily... 30 Dec 2009.
|
|
|
|
|
|
Murphy M. on NEWS: Aβ Immunotherapy—Muscling in on Inclusion Body Myositis, Dr. Askanas raises some excellent points. I would add that there is still substantial resistance... 19 May 2009.
|
|
|
|
|
|
Murphy M. on NEWS: DC: Dogs May Provide First Natural Animal Model for ALS, This work illustrates two frequently under-emphasized points about animal models of disease.... 2 Dec 2008.
|
|
|
|
|
|
Murphy M. on SITE POLL: Are you in favor of ICAD going annual?, I have to agree with the general sentiment that this is one meeting too many. The field doesn't... 17 Nov 2008.
|
|
|
|
|
|
Murphy M. on Alzforum: News: AD Vaccine, I'd be willing to bet that this would likely work. However, although a nice idea in principle,... 14 May 2008.
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
